Answers are grounded in this paper and cite their sources.
To our knowledge, these data are the first report of longitudinal proteomic and metabolomic molecular responses in patients after radiotherapy for cancers. The data supports innate immune activation as a critical clinical response of patients receiving radiotherapy for prostate cancer. Furthermore, we propose that the observed IIR may be generalized to the treatment of other cancer types, potentially informing multidisciplinary therapeutic strategies for cancer treatment.
No takes yet. Share an insight, caveat, or question.
Cheema et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: